Vaniprevir 300 mg

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Chronic Hepatitis CHepatitis C

Phase 1

A Study Investigating the Influence of Hepatic Insufficiency on the Pharmacokinetics of Vaniprevir (MK-7009-005)

CompletedNCT01010906

Merck Sharp & Dohme LLCHepatitis C

Start: 2009-07-01End: 2010-06-21Updated: 2018-10-09

Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048)

CompletedNCT01678131

Merck Sharp & Dohme LLCChronic Hepatitis C

Start: 2012-10-30End: 2013-09-02Updated: 2022-08-26

Related Papers

Fine‐Needle Aspiration for the Evaluation of Hepatic Pharmacokinetics of Vaniprevir: A Randomized Trial in Patients With Hepatitis C Virus Infection

Clinical Pharmacology & Therapeutics2019-12-23